Ocular Lesions in Brucella Infection: A Review of the Literature
Open Access
- 22 December 2022
- journal article
- review article
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 7601-7617
Abstract
Ocular lesions due to Brucella infection are uncommon and easily overlooked in clinical management, but must be differentiated from non-infectious eye diseases and treated promptly to protect the patient’s vision. We reviewed the relevant literature and identified 47 patients with ocular complications of Brucella infection. Among them, 28 showed ocular neuropathy, 15 presented with uveitis, and four patients displayed other ocular symptoms. Ocular symptoms accompanying Brucella infection require prompt diagnosis and treatment. The main methods of diagnosis are intraocular fluid tests and blood tests. Early diagnosis and treatment with suitable antibiotics are central to protecting the patient’s vision. Notably, in terms of mechanism of injury, Brucella infection is chronic and cannot be eliminated by phagocytes, and can cause damage to the eye by inducing autoimmune reactions, antigen-antibody complex production, release of endogenous and exogenous toxins, and bacterial production of septic thrombi in the tissues. In this review, we summarize the ocular symptoms, diagnosis, treatment and prognosis of Brucella infection, and discuss the mechanisms of Brucella in ocular lesions, providing a reference for the diagnosis and treatment of Brucella ocular lesions.Keywords
This publication has 143 references indexed in Scilit:
- Amplicon DNA Melting Analysis for the Simultaneous Detection of Brucella spp and Mycobacterium tuberculosis Complex. Potential Use in Rapid Differential Diagnosis between Extrapulmonary Tuberculosis and Focal Complications of BrucellosisPLOS ONE, 2013
- Global Burden of Human Brucellosis: A Systematic Review of Disease FrequencyPLOS Neglected Tropical Diseases, 2012
- What have we learned from brucellosis in the mouse model?Veterinary Research, 2012
- Efficacy and Tolerability of Antibiotic Combinations in Neurobrucellosis: Results of the Istanbul StudyAntimicrobial Agents and Chemotherapy, 2012
- Selective Subversion of Autophagy Complexes Facilitates Completion of the Brucella Intracellular CycleCell Host & Microbe, 2012
- Dendritic Cell and Macrophage Heterogeneity In VivoImmunity, 2011
- Idiopathic Intracranial HypertensionNeurologic Clinics, 2010
- Brucella Control of Dendritic Cell Maturation Is Dependent on the TIR-Containing Protein Btp1PLOS Pathogens, 2008
- Human brucellosisThe Lancet Infectious Diseases, 2007
- Brucella abortus Uses a Stealthy Strategy to Avoid Activation of the Innate Immune System during the Onset of InfectionPLOS ONE, 2007